NEW YORK, Nov. 4 (GenomeWeb News) - TurboWorx today said that Swedish drug discovery firm Karo Bio has purchased the TurboWorx suite of workflow automation software products.
TurboWorx said that Karo Bio has deployed the TurboWorx products in its Linux computing environment, which includes Linux workstations and a Linux cluster. The company is using the software to develop, automate, execute, and share scientific computational workflows in its computational biology and chemistry groups.
Karo Bio's modeling group plans to use the TurboWorx software to automate sequence alignments and load them into the Karo Bio Internal Target (KBIT) database. The group also plans to automate common modeling tasks such as virtual screening, combinational library design, and the batch calculation and loading of property predictions.
Financial terms of the licensing agreement were not disclosed.